SAHPRA Warns of Increased Brain Tumour Risk with Specific Contraceptive Use
January 17, 2025
Pretoria: The South African Health Products Regulatory Authority (SAHPRA) has advised that the product information for medroxyprogesterone acetate (MPA) be updated to include revised safety